Sisaf
SiSaf is a biopharmaceutical company developing RNA therapeutics for cancer and musculoskeletal disorders using its proprietary Bio-Courier technology. The platform combines bioabsorbable silicon with lipids and amino acids to deliver RNA therapeutics, addressing limitations of conventional lipid nanoparticles by enabling particles to be manufactured empty and loaded with RNA at the point of use, eliminating the…
Funding snapshot
About
SiSaf is a biopharmaceutical company developing RNA therapeutics for cancer and musculoskeletal disorders using its proprietary Bio-Courier technology. The platform combines bioabsorbable silicon with lipids and amino acids to deliver RNA therapeutics, addressing limitations of conventional lipid nanoparticles by enabling particles to be manufactured empty and loaded with RNA at the point of use, eliminating the need for ultra-cold supply chains. SiSaf's pipeline includes miRNA-based treatments for pancreatic cancer, siRNA-based therapies for metastatic cancer, and siRNA therapy for osteopetrosis ADO2, a rare skeletal disease. Founded in 2006 and headquartered in Belfast, United Kingdom, the company has raised approximately $32.6M in Series B funding from investors including Vickers Venture Partners, Croda, Invest Northern Ireland, and Co-Fund NI. SiSaf differentiates itself through its silicon-stabilized hybrid lipid nanoparticle technology enabling local manufacturing and stable supply chain for RNA therapeutics.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery > Encapsulation,
Drug Delivery > Nanoparticle Based
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.